The latest press releases issued by Two Rivers Public Health Department.
Salmonella Outbreak connected to a Wedding Reception in the Holdrege/Elm Creek area.
A clinical case of West Nile virus (WNV) has been detected in a human in the Two Rivers Public Health Department district. Laboratory testing for WNV is reported by hospitals or by locations collecting blood donations.
A horse in Dawson County has tested positive for West Nile Virus (WNV). Horse owners should work with their veterinarians to protect their horses against WNV.
The All of Us Research Program is inviting 1 million people across the United States to help build one of the most diverse health databases in history. It is put on by the National Institute of Health, and the goal is to get as many people from all backgrounds, in our case rural, and use the data to learn how our biology, lifestyle, and environment affect health in the hopes of finding ways to prevent and treat disease.
TRPHD is excited to announce that Kearney is now featured on the City Health Dashboard. Earlier this year, TRPHD partnered with the City of Kearney, the University of Nebraska at Kearney, Kearney Regional Medical Center, and Good Samaritan Hospital to apply for the 2nd annual City Health Dashboard Put Us on the Map Challenge - an opportunity for smaller cities to make their case for why their city should be added to the Dashboard.
Starting August 3rd, 2023 medicines and medical supplies that can be used to diagnose, prevent, or treat COVID-19 will only be available for purchase. Items previously purchased by the federal government, like vaccines, COVID-19 self-test kits, and personal protective equipment, will only be available through the health department until supplies run out.
Nebraska is seeing an uptick in cases of xylazine, otherwise known as the zombie drug, within the state. Xylazine, a non-opioid tranquilizer used in veterinary medicine, that, is infiltrating the drug supply and being mixed with other illicit substances—most commonly heroin and fentanyl.
Two Rivers Public Health Department’s Board of Health will be holding its regularly scheduled meeting in open session in accordance with the Nebraska Open Meets Act on Tuesday, June 6th, 2023. The meeting will begin at 6:00 PM.
The office, located at 516 W. 11th St. in Kearney, is closed on the following dates:
• Monday, May 29th, in observance of Memorial Day
• Monday, June 19, in observance of Juneteenth;
• Tuesday, July 4, in observance of Independence Day.
Regular office hours are 8:00 a.m. to 4:30 p.m., Monday through Friday. The office can be contacted at 888-669-7154.
KEARNEY –Two Rivers Public Health Department’s Board of Health will be holding its regularly scheduled meeting in a virtual format via Zoom in open session in accordance with the Nebraska Open Meets Act on Tuesday, October 4th, 2022. The meeting will begin at 6:00 PM.
The meeting’s agenda is continuously updated and available on the department website at trphd.ne.gov or by contacting Jeremy Eschliman, Health Director at 1-888-669-7154.
Public members are encouraged to attend virtually on Zoom at:
https://us02web.zoom.us/j/874797624?pwd=L0FDdzEvazk0TDdJWEw3a0U3bExXUT09
Password: 12345678
Two Rivers Public Health Department encourages all citizens to vaccinate themselves for the coming cold and flu season. Two Rivers Public Health Department is now able to administer all types of COVID-19 booster vaccines and flu vaccines.
With today’s authorization [8/31/22], the FDA has also revised the EUA of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to remove the use of the monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines for booster administration for individuals 18 years of age and older and 12 years of age and older, respectively. These monovalent vaccines continue to be authorized for use for administration of a primary series for individuals 6 months of age and older as described in the letters of authorization. At this time, the Pfizer-BioNTech COVID-19 Vaccine remains authorized for administration of a single booster dose for individuals 5 through 11 years of age at least five months after completing a primary series of the Pfizer-BioNTech COVID-19 Vaccine.
